bibliographic entry 12595313 [be/12595313]
https://w3id.org/oc/corpus/be/12595313

is a
content
  • Giusti, RM, Shastri, K, Pilaro, AM. U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine, oxaliplatin, and irinotecan-containing chemotherapy regimens, Clin Cancer Res, 2008, 14, 1296, 1302, PMID: 18316547
references